Pages that link to "Q34569335"
Jump to navigation
Jump to search
The following pages link to Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort (Q34569335):
Displaying 25 items.
- HIV outcomes in Hepatitis B virus coinfected individuals on HAART (Q33665820) (← links)
- The influence of HIV-1 subtypes C, CRF31_BC and B on disease progression and initial virologic response to HAART in a Southern Brazilian cohort (Q33859741) (← links)
- Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire (Q34097961) (← links)
- Progress realized: trends in HIV-1 viral load and CD4 cell count in a tertiary-care center from 1999 through 2011 (Q34599593) (← links)
- Disparities in viral load and CD4 count trends among HIV-infected adults in South Carolina (Q34802519) (← links)
- Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis (Q35064203) (← links)
- Repeated assessments of food security predict CD4 change in the setting of antiretroviral therapy. (Q35175836) (← links)
- Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption? (Q35491883) (← links)
- Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study (Q35623357) (← links)
- Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort (Q35873534) (← links)
- Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings (Q35905907) (← links)
- Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men. (Q36187651) (← links)
- Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort (Q36275359) (← links)
- U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. (Q36501102) (← links)
- Virologic and immunologic outcome of HAART in Human Immunodeficiency Virus (HIV)-1 infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, Ethiopia (Q37033512) (← links)
- Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy (Q37207042) (← links)
- Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected Late Presenters (Q37447469) (← links)
- Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration (Q37490654) (← links)
- Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now. (Q38625214) (← links)
- Long-term clinical and immunologic outcomes of HIV-infected women with and without previous exposure to nevirapine. (Q38866322) (← links)
- HIV community viral load trends in South Carolina (Q40363630) (← links)
- Three different patterns of CD4 recovery in a cohort of Chinese HIV patients following antiretroviral therapy - a five-year observational study. (Q41716615) (← links)
- Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. (Q45930474) (← links)
- Cost Effectiveness of Dolutegravir as a First-Line Treatment Option in the HIV-1-Infected Treatment-Naive Patients in Russia (Q57185635) (← links)
- Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients (Q91893673) (← links)